Pretreatment with Interleukin-2 Modulates Perioperative Immunodysfunction in Patients with Renal Cell Carcinoma Cited by

Fol. Biol. 2003, 49, 63-68

https://doi.org/10.14712/fb2003049020063

Pretreatment with Interleukin-2 Modulates Perioperative Immunodysfunction in Patients with Renal Cell Carcinoma

Malte Böhm¹, A. Ittenson², T. Klatte¹, K. F. Schierbaum¹, F.-W. Röhl³, S. Ansorge², E. P. Allhoff¹

¹Department of Urology, Otto-von-Guericke-University, Magdeburg, Germany
²Institute of Experimental Internal Medicine, Otto-von-Guericke-University, Magdeburg, Germany
³Institute of Biometrics and Medical Informatics, Otto-von-Guericke-University, Magdeburg, Germany

Received January 2003
Accepted February 2003

Crossref Cited-by Linking

Angka Leonard, Khan Sarwat, Kilgour Marisa, Xu Rebecca, Kennedy Michael, Auer Rebecca: Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery. IJMS 2017, 18, 1787. <https://doi.org/10.3390/ijms18081787>
Horowitz Maya, Neeman Elad, Sharon Eran, Ben-Eliyahu Shamgar: Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 2015, 12, 213. <https://doi.org/10.1038/nrclinonc.2014.224>